Klaus Metzeler 🇺🇦 (@klausmetzelermd) 's Twitter Profile
Klaus Metzeler 🇺🇦

@klausmetzelermd

Physician-scientist, leukemia geneticist, amateur photographer

ID: 1665520248

linkhttps://www.webofscience.com/wos/author/record/1465456 calendar_today12-08-2013 17:05:55

1,1K Tweet

1,1K Followers

1,1K Following

Maximilian Stahl (@maxstahlmd) 's Twitter Profile Photo

Update: Cigna Healthcare after a peer to peer review Cigna Healthcare denied my request. It was denied by a family medicine practitioner who has never in their life treated a patient with leukemia. In what world are we living here? Cigna Healthcare is this how you treat your patients? Really? Do better!!

Jennifer Trowbridge (@trowbridgelab) 's Twitter Profile Photo

Thank you, Connie, for your pioneering work in hematopoietic stem cell biology, for being an inspiration to us women in science, for your vision, your mentorship, your kindness. The legacy and impact of your ideas and research will live on and never be forgotten ❤️

Vincent Rajkumar (@vincentrk) 's Twitter Profile Photo

Breaking: ODAC votes 11-0 to recommend approval of ciltacel in patients with relapsed/refractory multiple myeloma in earlier stages. I’m glad. Right call. But we need to be careful. Read on. cancernetwork.com/view/odac-cast…

CALL TO ACTIVISM (@calltoactivism) 's Twitter Profile Photo

A British writer penned the best description of Donald Trump I’ve ever read: “Why do some British people not like Donald Trump?” A few things spring to mind. Trump lacks certain qualities which the British traditionally esteem. For instance, he has no class, no charm, no

Lior Pachter (@lpachter) 's Twitter Profile Photo

The choice of whether to use Seurat or Scanpy for single-cell RNA-seq analysis typically comes down to a preference of R vs. Python. But do they produce the same results? In biorxiv.org/content/10.110… w/ Joseph Rich et al. we take a close look. The results are 👀 1/🧵

The choice of whether to use Seurat or Scanpy for single-cell RNA-seq analysis typically comes down to a preference of R vs. Python. But do they produce the same results? In biorxiv.org/content/10.110… w/ <a href="/Josephmrich/">Joseph Rich</a> et al. we take a close look. The results are 👀 1/🧵
ESH (Haematology) (@eshaematology) 's Twitter Profile Photo

#ESHMDS2024: Many thanks to FENAUX Pierre, katharina goetze, Mikkael A. Sekeres MD, MS for building such an interesting programme, to all faculty for a great meeting & to all participants for the lively interactions! Do not miss upcoming #ESHCONFERENCES → esh.org #HAEMATOLOGY

#ESHMDS2024: Many thanks to <a href="/FenauxP/">FENAUX Pierre</a>, <a href="/GoetzeKatharina/">katharina goetze</a>, <a href="/MikkaelSekeres/">Mikkael A. Sekeres MD, MS</a> for building such an interesting programme, to all faculty for a great meeting &amp; to all participants for the lively interactions!
Do not miss upcoming #ESHCONFERENCES → esh.org
#HAEMATOLOGY
Marius Raabe (@marius_raabe) 's Twitter Profile Photo

Die AfD ist eine Partei, wenn nicht gar des Hasses und der Lüge, so zumindest des kindischen Trotzes und der Engstirnigkeit. Sie ist das Kleinkind am Strand, das die Sandburgen der anderen zerstört, weil seine nicht genug bewundert wird. Will man so sein?

Eddie Cliff (@eddie_cliff) 's Twitter Profile Photo

Updated 2023 impact factor list for hematology/oncology journals Interesting to see the post-COVID reductions as we get closer to normal (Will add the few I'm missing when I get them) #medtwitter #hematology #IF #impactfactor

Updated 2023 impact factor list for hematology/oncology journals

Interesting to see the post-COVID reductions as we get closer to normal

(Will add the few I'm missing when I get them) #medtwitter #hematology #IF #impactfactor
Jürgen Zimmerer (@juergenzimmerer) 's Twitter Profile Photo

Nochmals zur #Fördergeldaffäre, die eigentlich eine #Machtmissbrauchsaffäre ist. Offenbar haben sich FDP und sie unterstützende Medien dafür entschieden, die Ministerin zu halten, indem sie die Affäre zu einem Streit über Israel und Antisemitismus zu machen. Sie lenken damit

Eva Vivalt (@evavivalt) 's Twitter Profile Photo

We are happy to release the first results of a RCT of a US program that provided $1,000/month unconditionally for 3 years to 1,000 individuals in the treatment group, with a group of 2,000 people receiving $50/month serving as the control. These are sizable transfers. 1/ 🧵

We are happy to release the first results of a RCT of a US program that provided $1,000/month unconditionally for 3 years to 1,000 individuals in the treatment group, with a group of 2,000 people receiving $50/month serving as the control.

These are sizable transfers. 1/ 🧵
Manni Mohyuddin (@mannimd1) 's Twitter Profile Photo

The GEM-CESAR trial of a super aggressive approach to SMM (KRD>Transplant>KR>Len) just got published. The results are a stunning verdict against early intervention in SMM, despite the way the results are potrayed. Here is a peer review and critical appraisal of this #mmsm 🧵

The GEM-CESAR trial of a super aggressive approach to SMM (KRD&gt;Transplant&gt;KR&gt;Len) just got published.

The results are a stunning verdict against early intervention in SMM, despite the way the results are potrayed.

Here is a peer review and critical appraisal of this
#mmsm
🧵